Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

The Network for Multidisciplinary Studies
on ARV-based HIV Prevention

welcome to

NEMUS

  • Science
  • Policy
  • HIV Prevention

Agenda

Please find here a list of activities planned for 2014 that are relevant to NEMUS' activities. This list is updated on a regular basis.

  • 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016)

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

     

     

    Read more

    close
    23rd Conference on Retroviruses and Opportunistic Infections (CROI 2016)

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016 will be held from February 22 to February 25, 2016, in Boston, Massachusetts, at the Hynes Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2016 will be available online via webcast.

     

    Read more

  • HIV & Hepatitis Clinical Pharmacology Workshop 2016

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

     

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

     

     

    Read more

    close
    HIV & Hepatitis Clinical Pharmacology Workshop 2016

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

     

    The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

     

    Read more

  • 21st International AIDS Conference (AIDS 2016)

    The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

    The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

     

     

    Read more

    close
    21st International AIDS Conference (AIDS 2016)

    The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

    The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

     

    Read more

  • HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based…

     

    HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

    Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

     

    Read more

    close
    HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P 2016)

     

    HIVR4P is the world's only scientific meeting dedicated exclusively to the latest research on all forms of biomedical HIV prevention. Through both abstract and non-abstract-driven sessions, HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to each modality. We expect this cutting-edge, global conference to attract between 1,200 and 1,500 leaders in HIV prevention research, programs, and policy to Chicago.

    Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2016, 17-20 October in Chicago.

    Read more

  • 19th Annual United States Conference on AIDS 2015

     

    The 19th annual United States Conference on AIDS(USCA), will take place September 10-13, 2015, at the new Washington Marriott Marquis hotel located at 901 Massachusetts Avenue, NW in Washington, DC. For nearly two decades, USCA has sought to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking.

     

     

    Read more

    close
    19th Annual United States Conference on AIDS 2015

     

    The 19th annual United States Conference on AIDS(USCA), will take place September 10-13, 2015, at the new Washington Marriott Marquis hotel located at 901 Massachusetts Avenue, NW in Washington, DC. For nearly two decades, USCA has sought to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking.

     

    Read more

  • International Society for Sexually Transmitted Diseases Research 2015

     

    The International Society for Sexually Transmitted Diseases Research exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the Society was founded, the ISSTDR meetings have been the premier scientific conferences that address the entire breadth of research on STD, including HIV infections and the acquired immunodeficiency syndrome, and encompassing microbiology, virology, immunobiology, pathogenesis, and other basic sciences; clinical sciences, social and behavioral sciences, epidemiology, and prevention; and research in health services, public health, and prevention policy.

     

    ISSTDR was founded in 1977 and is governed by an international Board of Directors who currently represent 7 countries. The ISSTDR Conference Support Foundation provides support in respect of the conferences of the ISSTDR.

     

    The 21st Meeting of the ISSTDR will take place as a joint meeting with IUSTI World at the Brisbane Convention and Exhibition Centre, Australia from September 13 to 16, 2015.

     

     

    Read more

    close
    International Society for Sexually Transmitted Diseases Research 2015

     

    The International Society for Sexually Transmitted Diseases Research exists to promote research on sexually transmitted diseases and facilitate the timely exchange of information among research investigators. To these ends, ISSTDR sponsors a biennial, interdisciplinary scientific meeting, at venues that historically have alternated between Europe and North America. During the three decades since the Society was founded, the ISSTDR meetings have been the premier scientific conferences that address the entire breadth of research on STD, including HIV infections and the acquired immunodeficiency syndrome, and encompassing microbiology, virology, immunobiology, pathogenesis, and other basic sciences; clinical sciences, social and behavioral sciences, epidemiology, and prevention; and research in health services, public health, and prevention policy.

     

    ISSTDR was founded in 1977 and is governed by an international Board of Directors who currently represent 7 countries. The ISSTDR Conference Support Foundation provides support in respect of the conferences of the ISSTDR.

     

    The 21st Meeting of the ISSTDR will take place as a joint meeting with IUSTI World at the Brisbane Convention and Exhibition Centre, Australia from September 13 to 16, 2015.

     

    Read more

NEMUS' Activities

  • NEMUS Webinar Latina# 9: "Contribuciones Clave de la Conferencia IAS…

    Estimadas y estimados colegas:

     

    Tenemos el agrado de iniciar una nueva fase de la Serie de Webinars Latinos de NEMUS, esta vez como parte de los esfuerzos de diseminación de conocimiento del proyecto imPrEP, un proyecto demostrativo de Implementación de la PrEP en servicios públicos de salud en Brasil, México y Perú, apoyado por UNITAID (se realizará una presentación específica sobre este proyecto en breve).

    Como sabemos, finalmente se observa un avance en los esfuerzos globales para visibilizar las oportunidades ofrecidas por la PrEP para fortalecer la prevención del VIH, y las conferencias internacionales de VIH han ofrecido tradicionalmente visiones panorámicas acerca tanto de los debates científicos (incluyendo los productos de próxima disponibilización) y el progreso en implementación. Dado que la reviente Conferencia de la IAS en Paris (23-26 Julio 2017) representa un buen ejemplo de dicha tendencia, en esta ocasión tendremos el honor de recibir al Dr. Omar Sued, Director de Investigación de la Fundación Huesped, Buenos Aires, con la presentación:

     

    "Contribuciones Clave de la Conferencia IAS 2017 a los Esfuerzos Globales en PrEP"

     

    Esta conferencia en español se realizará el día Jueves 14 de Septiembre de 2017 a las 7am (Los Angeles), 9am (Lima, C. de Mexico, C. de Panamá), 10am (Nueva York, Santiago), 11am (Brasilia, Rio, Buenos Aires); 3pm (Londres), 4pm (Hora Central Europea), 7.30pm (Delhi), 9pm (Bangkok).

    (NOTA: la misma presentación se ofrecerá en Inglés el día anterior, Miercoles 13 de Septiembre)

    Para otros países/ciudades, por favor visite:

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Omar 1

    El Dr. Omar Sued es Médico Especialista en Medicina Interna y Enfermedades Infecciosas, Magister en Manejo Integral del VIH-Sida, y Doctor en Medicina (Universidad de Barcelona). Se dedica a la atención de personas VIH desde 1997 en diversos ámbitos. Entre 2009 y 2012 fue Asesor Regional para Tratamiento de VIH-Sida para la Organización Panamericana de la Salud donde apoyó la actualización de las guías de tratamiento antirretroviral para mas de 18 países. Desde 2012 es Director de Investigaciones de la Fundación Huésped de Argentina. Fue Presidente del XVI Congreso Nacional de Infectología de Argentina, y actualmente es Secretario de la Sociedad Argentina de Infectología.

    Para registrarse al webinar, por favor ingrese a:

    https://goo.gl/forms/fewkFsAplFqzVbZv1


    Para acceder al webinar en la fecha y hora señalada utilice el siguiente Link

    https://global.gotomeeting.com/join/973574701


    Esperamos contar con su participacion

     

     

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Latina# 9: "Contribuciones Clave de la Conferencia IAS 2017 a los Esfuerzos Globales en PrEP"

    Estimadas y estimados colegas:

     

    Tenemos el agrado de iniciar una nueva fase de la Serie de Webinars Latinos de NEMUS, esta vez como parte de los esfuerzos de diseminación de conocimiento del proyecto imPrEP, un proyecto demostrativo de Implementación de la PrEP en servicios públicos de salud en Brasil, México y Perú, apoyado por UNITAID (se realizará una presentación específica sobre este proyecto en breve).

    Como sabemos, finalmente se observa un avance en los esfuerzos globales para visibilizar las oportunidades ofrecidas por la PrEP para fortalecer la prevención del VIH, y las conferencias internacionales de VIH han ofrecido tradicionalmente visiones panorámicas acerca tanto de los debates científicos (incluyendo los productos de próxima disponibilización) y el progreso en implementación. Dado que la reviente Conferencia de la IAS en Paris (23-26 Julio 2017) representa un buen ejemplo de dicha tendencia, en esta ocasión tendremos el honor de recibir al Dr. Omar Sued, Director de Investigación de la Fundación Huesped, Buenos Aires, con la presentación:

     

    "Contribuciones Clave de la Conferencia IAS 2017 a los Esfuerzos Globales en PrEP"

     

    Esta conferencia en español se realizará el día Jueves 14 de Septiembre de 2017 a las 7am (Los Angeles), 9am (Lima, C. de Mexico, C. de Panamá), 10am (Nueva York, Santiago), 11am (Brasilia, Rio, Buenos Aires); 3pm (Londres), 4pm (Hora Central Europea), 7.30pm (Delhi), 9pm (Bangkok).

    (NOTA: la misma presentación se ofrecerá en Inglés el día anterior, Miercoles 13 de Septiembre)

    Para otros países/ciudades, por favor visite:

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Omar 1

    El Dr. Omar Sued es Médico Especialista en Medicina Interna y Enfermedades Infecciosas, Magister en Manejo Integral del VIH-Sida, y Doctor en Medicina (Universidad de Barcelona). Se dedica a la atención de personas VIH desde 1997 en diversos ámbitos. Entre 2009 y 2012 fue Asesor Regional para Tratamiento de VIH-Sida para la Organización Panamericana de la Salud donde apoyó la actualización de las guías de tratamiento antirretroviral para mas de 18 países. Desde 2012 es Director de Investigaciones de la Fundación Huésped de Argentina. Fue Presidente del XVI Congreso Nacional de Infectología de Argentina, y actualmente es Secretario de la Sociedad Argentina de Infectología.

    Para registrarse al webinar, por favor ingrese a:

    https://goo.gl/forms/fewkFsAplFqzVbZv1


    Para acceder al webinar en la fecha y hora señalada utilice el siguiente Link

    https://global.gotomeeting.com/join/973574701


    Esperamos contar con su participacion

     

     

     

    Read more

  • NEMUS Webinar Series # 30:"Key Contributions of the 2017 IAS…

    Dear colleague:

     

    We are pleased to start a new phase of the NEMUS Webinar Series, this time as part of the knowledge sharing efforts of the imPrEP Project, a Demonstration Project on PrEP Implementation in public health facilities in Brazil, Mexico and Peru, supported by UNITAID (a specific presentation will focus on this project in the near future).

    As we know, global endeavors to ensure a better awareness of the opportunities offered by PrEP to strengthen HIV prevention are finally moving foward, and the International HIV Conferences have traditionally offered snapshots of both scientific debates (including related opportunities in the pipeline) and implementation progress. As the recent IAS Conference in Paris (23-26 July 2017) offers a good example of that trend, this time around we will be honored to host Dr. Omar Sued, Director of Research at Fundación Huesped, Buenos Aires, presenting on:

     

    "Key Contributions of the 2017 IAS Conference to the Global PrEP Efforts"

     

    This presentation will take place in English on Wednesday 13 September 2017 at 7am (Los Angeles), 9am (Lima, Mexico City, Panama City), 10am (New York, Santiago), 11am (Brasilia, Buenos Aires); 3pm (London), 4pm (Central European Time), 7.30pm (Delhi); 9pm (Bangkok).

    (NOTE: the same presentation will be offered in Spanish on Thursday 14 September)

    To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Omar 1

    Dr. Omar Sued is a specialist in Internal Medicine and Infectious Diseases, Master in Comprehensive Management of HIV/AIDS and Doctor of Medicine (University of Barcelona). He has been working in various fields of HIV care since 1997. From 2009 to 2012, he was a Regional Advisor on HIV Treatment for the Pan American Health Organization, where he helped in updating the antiretroviral treatment guidelines for more than 18 countries. Since 2012 he is Director of Research at the Huésped Foundation of Argentina. He was the President of the XVI National Congress of Infectology in Argentina (2016), and currently he is the Secretary of the Argentinian Society of Infectology.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

    To access the webinar ​at the indicated ​date/​time​, please​ click on the following link:

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Series # 30:"Key Contributions of the 2017 IAS Conference to the Global PrEP Efforts"

    Dear colleague:

     

    We are pleased to start a new phase of the NEMUS Webinar Series, this time as part of the knowledge sharing efforts of the imPrEP Project, a Demonstration Project on PrEP Implementation in public health facilities in Brazil, Mexico and Peru, supported by UNITAID (a specific presentation will focus on this project in the near future).

    As we know, global endeavors to ensure a better awareness of the opportunities offered by PrEP to strengthen HIV prevention are finally moving foward, and the International HIV Conferences have traditionally offered snapshots of both scientific debates (including related opportunities in the pipeline) and implementation progress. As the recent IAS Conference in Paris (23-26 July 2017) offers a good example of that trend, this time around we will be honored to host Dr. Omar Sued, Director of Research at Fundación Huesped, Buenos Aires, presenting on:

     

    "Key Contributions of the 2017 IAS Conference to the Global PrEP Efforts"

     

    This presentation will take place in English on Wednesday 13 September 2017 at 7am (Los Angeles), 9am (Lima, Mexico City, Panama City), 10am (New York, Santiago), 11am (Brasilia, Buenos Aires); 3pm (London), 4pm (Central European Time), 7.30pm (Delhi); 9pm (Bangkok).

    (NOTE: the same presentation will be offered in Spanish on Thursday 14 September)

    To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Omar 1

    Dr. Omar Sued is a specialist in Internal Medicine and Infectious Diseases, Master in Comprehensive Management of HIV/AIDS and Doctor of Medicine (University of Barcelona). He has been working in various fields of HIV care since 1997. From 2009 to 2012, he was a Regional Advisor on HIV Treatment for the Pan American Health Organization, where he helped in updating the antiretroviral treatment guidelines for more than 18 countries. Since 2012 he is Director of Research at the Huésped Foundation of Argentina. He was the President of the XVI National Congress of Infectology in Argentina (2016), and currently he is the Secretary of the Argentinian Society of Infectology.

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

    To access the webinar ​at the indicated ​date/​time​, please​ click on the following link:

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

    Read more

  • NEMUS Webinar Series # 29:"Access to PrEP in Spain: Challenges…

    Dear colleague:

     

    PrEP uptake is slowly moving forward around the globe. In some cases it is being implemented as part of a governmental decision, while in others, It is the initiative of potential users and their communities, as well as ​of ​champions among health providers, ​what play​s​ a ​key ​role. This seems to be the case in Spain, where, as in other European countries, cost issues represent a barrier at this time, but new opportunities may be emerging​.​

    In our upcoming webinar, scheduled for Thursday 25 May at 9h (Mexico City, Panama City, Lima)​ 10h ​(New​ York), 11h (Brasilia). 16h (Barcelona). We will have Dr. Pep Coll and Mr. Michael Meulbroek presenting medical and community perspectives​, respectively,​ on:

    Access to PrEP in Spain: Challenges and Ongoing Efforts

     

    We are sure at the case of Spain will help identify and start the discussion on issues that may be relevant to other realities.

    Pep Coll

    Pep Coll, MD is the Clinical Cohorts Coordinator of the HIVACAT Programme (Project for the development of HIV vaccines) at the irsiCaixa AIDS Research Institute, and physician at the HIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona. He collaborates in the recruitment and follow up of several cohorts (HIV acute infections, controllers, rapid progressors, HESN), and he have conducted cohort studies of HIV-uninfected men who have sex with men (MSM), in collaboration with a community based organization (BCN Checkpoint). Another of his fields is the Human Papillomavirus, collaborating in the programme for the prevention of anal cancer in HIV-infected patients. Dr. Coll is currently focused on strategies for prevention of HIV (including PrEP) and other STI among at-risk MSM in Barcelona, in collaboration with BCN Checkpoint.

     

    Michael Meulbroek

    Michael Meulbroek Chair of Projecte dels NOMS-Hispanosida. Michael was born in Amsterdam in 1959, and has lived in Barcelona, Spain, since 1986, where he was diagnosed with HIV. In 1993 he co-founded Projecte dels NOMS-Hispanosida, one of Spain’s most important HIV/AIDS community-based organizations. He is also a treatment counselor and educator within INFOTRAT, a peer focused information and education program for people living with HIV/AIDS (PLHIVA). In 1998 co-founder of ATOS (Association for Organ Transplants to persons living with HIV), an organization which promotes access for people with HIV and HCV co-infection to the Organ Transplant program, resulting in the first liver transplant in 2002. His latest project in 2006, has been the implementation of the BCN Checkpoint, a community based centre of HIV and STI detection for Men who have Sex with Men and development of community research. Michael is also member of the European AIDS Treatment Group, community member of the INSIGHT Network and HIVACAT.

     

     

    The webinar is scheduled to take place on Thursday 25 May, 2017,at 7:00 am Los Angeles; 9:00 ​Mexico City, ​Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 2​:00 London; ​16​:00 ​(Barcelona, G​eneva​, Johannesburg​)​; ​19.30 ​(Delhi), ​21:00​ ​Bangkok. To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/Jc5ryeILPuf6Z4Jv2

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Series # 29:"Access to PrEP in Spain: Challenges and Ongoing Efforts"

    Dear colleague:

     

    PrEP uptake is slowly moving forward around the globe. In some cases it is being implemented as part of a governmental decision, while in others, It is the initiative of potential users and their communities, as well as ​of ​champions among health providers, ​what play​s​ a ​key ​role. This seems to be the case in Spain, where, as in other European countries, cost issues represent a barrier at this time, but new opportunities may be emerging​.​

    In our upcoming webinar, scheduled for Thursday 25 May at 9h (Mexico City, Panama City, Lima)​ 10h ​(New​ York), 11h (Brasilia). 16h (Barcelona). We will have Dr. Pep Coll and Mr. Michael Meulbroek presenting medical and community perspectives​, respectively,​ on:

    Access to PrEP in Spain: Challenges and Ongoing Efforts

     

    We are sure at the case of Spain will help identify and start the discussion on issues that may be relevant to other realities.

    Pep Coll

    Pep Coll, MD is the Clinical Cohorts Coordinator of the HIVACAT Programme (Project for the development of HIV vaccines) at the irsiCaixa AIDS Research Institute, and physician at the HIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona. He collaborates in the recruitment and follow up of several cohorts (HIV acute infections, controllers, rapid progressors, HESN), and he have conducted cohort studies of HIV-uninfected men who have sex with men (MSM), in collaboration with a community based organization (BCN Checkpoint). Another of his fields is the Human Papillomavirus, collaborating in the programme for the prevention of anal cancer in HIV-infected patients. Dr. Coll is currently focused on strategies for prevention of HIV (including PrEP) and other STI among at-risk MSM in Barcelona, in collaboration with BCN Checkpoint.

     

    Michael Meulbroek

    Michael Meulbroek Chair of Projecte dels NOMS-Hispanosida. Michael was born in Amsterdam in 1959, and has lived in Barcelona, Spain, since 1986, where he was diagnosed with HIV. In 1993 he co-founded Projecte dels NOMS-Hispanosida, one of Spain’s most important HIV/AIDS community-based organizations. He is also a treatment counselor and educator within INFOTRAT, a peer focused information and education program for people living with HIV/AIDS (PLHIVA). In 1998 co-founder of ATOS (Association for Organ Transplants to persons living with HIV), an organization which promotes access for people with HIV and HCV co-infection to the Organ Transplant program, resulting in the first liver transplant in 2002. His latest project in 2006, has been the implementation of the BCN Checkpoint, a community based centre of HIV and STI detection for Men who have Sex with Men and development of community research. Michael is also member of the European AIDS Treatment Group, community member of the INSIGHT Network and HIVACAT.

     

     

    The webinar is scheduled to take place on Thursday 25 May, 2017,at 7:00 am Los Angeles; 9:00 ​Mexico City, ​Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 2​:00 London; ​16​:00 ​(Barcelona, G​eneva​, Johannesburg​)​; ​19.30 ​(Delhi), ​21:00​ ​Bangkok. To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/Jc5ryeILPuf6Z4Jv2

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

    Read more

  • NEMUS 2nd Special Issue on PrEP in JIAS:Global implementation of…

     Jias2016


    NEMUS 2nd Special Issue on PrEP in JIAS:

     

     

    Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges


    Fifteen months after the publication of​ its first supplement on P​re-Exposure Prophylaxis (i.e. PrEP Implementation Science: State-of-the-Art and Research Agenda), NEMUS, in collaboration with UNAIDS, is pleased to share this new collection of contributions focused on PrEP roll-out, identifying barriers and solutions, with a focus on regions and populations not considered before. ​

    ​The papers included in this new series​ are authored ​by some of the main reseachers, policy makers and advocates who have something valuable to share concerning PrEP today. Together with other tools that will be published soon, such as the upcoming WHO implementation guidelines, this publication will help to document progress and guide implementers through a rapidly changing field.

     

    Editorial

    No one left behind: how are we doing in the roll-out of PrEP as part of combination HIV prevention? 
    Carlos F Cáceres, Linda-Gail Bekker, Peter Godfrey-Faussett

    Debate

    Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America
    Giovanni Ravasi, Beatriz Grinsztejn, Ricardo Baruch, Juan Vicente Guanira, Ricardo Luque, Carlos F Cáceres, Massimo Ghidinelli

    Review

    The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices
    Jae M Sevelius, Madeline B Deutsch, Robert Grant

    Research

    PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa
    Jessica B McGillen, Sarah-Jane Anderson, Timothy B Hallett

    Commentary

    Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection:
    progress and emerging issues in research and policy
    Carlos F Cáceres, Annick Borquez, Jeffrey D Klausner, Rachel Baggaley, Chris Beyrer

    PrEP implementation research in Africa: what is new?
    Frances M Cowan, Sinead Delany-Moretlwe, Eduard J Sanders, Nelly R Mugo,
    Fernand Aime Guedou, Michel Alary, Luc Behanzin, Owen Mugurungi, Linda-Gail Bekker

    PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers
    Iryna Zablotska, Andrew E Grulich, Nittaya Phanuphak, Tarandeep Anand, Surang Janyam,
    Midnight Poonkasetwattana, Rachel Baggaley, Frits van Griensven, Ying-Ru Lo

    PrEP in Europe – expectations, opportunities and barriers 
    Sheena Mary McCormack, Veronica Noseda, Jean-Michel Molina

    Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
    Sybil Hosek, Connie Celum, Craig M Wilson, Bill Kapogiannis, Sinead Delany-Moretlwe, Linda-Gail Bekker

    Commentary: the value of PrEP for people who inject drugs 
    Rosalind L Coleman, Susie McLean

    Viewpoint

    PrEP: controversy, agency and ownership 
    Gus P Cairns, Kane Race, Pedro Goicochea

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS 2nd Special Issue on PrEP in JIAS:Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges

     Jias2016


    NEMUS 2nd Special Issue on PrEP in JIAS:

     

     

    Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges


    Fifteen months after the publication of​ its first supplement on P​re-Exposure Prophylaxis (i.e. PrEP Implementation Science: State-of-the-Art and Research Agenda), NEMUS, in collaboration with UNAIDS, is pleased to share this new collection of contributions focused on PrEP roll-out, identifying barriers and solutions, with a focus on regions and populations not considered before. ​

    ​The papers included in this new series​ are authored ​by some of the main reseachers, policy makers and advocates who have something valuable to share concerning PrEP today. Together with other tools that will be published soon, such as the upcoming WHO implementation guidelines, this publication will help to document progress and guide implementers through a rapidly changing field.

     

    Editorial

    No one left behind: how are we doing in the roll-out of PrEP as part of combination HIV prevention? 
    Carlos F Cáceres, Linda-Gail Bekker, Peter Godfrey-Faussett

    Debate

    Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America
    Giovanni Ravasi, Beatriz Grinsztejn, Ricardo Baruch, Juan Vicente Guanira, Ricardo Luque, Carlos F Cáceres, Massimo Ghidinelli

    Review

    The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices
    Jae M Sevelius, Madeline B Deutsch, Robert Grant

    Research

    PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa
    Jessica B McGillen, Sarah-Jane Anderson, Timothy B Hallett

    Commentary

    Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection:
    progress and emerging issues in research and policy
    Carlos F Cáceres, Annick Borquez, Jeffrey D Klausner, Rachel Baggaley, Chris Beyrer

    PrEP implementation research in Africa: what is new?
    Frances M Cowan, Sinead Delany-Moretlwe, Eduard J Sanders, Nelly R Mugo,
    Fernand Aime Guedou, Michel Alary, Luc Behanzin, Owen Mugurungi, Linda-Gail Bekker

    PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers
    Iryna Zablotska, Andrew E Grulich, Nittaya Phanuphak, Tarandeep Anand, Surang Janyam,
    Midnight Poonkasetwattana, Rachel Baggaley, Frits van Griensven, Ying-Ru Lo

    PrEP in Europe – expectations, opportunities and barriers 
    Sheena Mary McCormack, Veronica Noseda, Jean-Michel Molina

    Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
    Sybil Hosek, Connie Celum, Craig M Wilson, Bill Kapogiannis, Sinead Delany-Moretlwe, Linda-Gail Bekker

    Commentary: the value of PrEP for people who inject drugs 
    Rosalind L Coleman, Susie McLean

    Viewpoint

    PrEP: controversy, agency and ownership 
    Gus P Cairns, Kane Race, Pedro Goicochea

     

    Read more

  • NEMUS Webinar Series # 28:"The PrEP Task Force in Latin…

    Dear colleague:

     

    After the completion of important studies providing evidence of the efficacy of PrEP for HIV prevention in various populations, translated into technical recommendations for use by people at increased risk in the context of combination HIV prevention, released by WHO, it is necessary to focus increasingly on tasks that will support countries in assessing the potential role of PrEP in their HIV prevention responses, based on evidence, and eventually help in the roll-out of PrEP as one option for HIV prevention to be used by those who need and want it.

    One of those initiatives is the PrEP Task Force in Latin America and the Caribbean, which emerged as a joint initiative of the PAHO HIV Program (through Dr. Giovanni Ravasi) and NEMUS (through Dr. Carlos Cáceres).

    At this time, we are pleased to announce the next NEMUS Global Webinar to be focused on

    The PrEP Task Force in Latin America and the Caribbean: A model of technical support for evidence-based HIV PrEP Implementation

     

    Giovanni Ravasi

    Giovanni Ravasi. is a Medical Doctor, specialized in Infectious Diseases from the Universitá degli Studi of Pavia, Italy, and holds a Master Degree in Public Health from the London School of Hygiene in Tropical Medicine, London, UK. Since 2008 works as Regional Adviser on HIV for the Pan American Health Organization (PAHO), Regional office of the World Health Organization (WHO), based in Brasilia, Brazil, until 2013, and since 2014 in the Regional Headquarter in Washington DC, USA. His main areas of work are HIV drug resistance surveillance, prevention and control, technical cooperation for HIV care and treatment public health policy development, implementation and monitoring and evaluation.

     

    Ioannis

    Dr. Ioannis (Yannis) Hodges-Mameletzis, WHO. He is an HIV molecular epidemiologist and biologist by training, based in Geneva, Switzerland. He is currently consulting on PrEP at WHO Headquarters and is involved in supporting countries around the technical and programmatic issues around PrEP implementation. He has been extensively involved in the development of evidence-based recommendations for HIV and viral hepatitis at WHO.

     

    carlosfcaceresp 200

    Carlos Cáceres, MD, MPH, PhD. is a Professor of Public Health, and Director of the Center for Interdisciplinary Studies in HIV, AIDS and Society at Cayetano Heredia University (UPCH) in Lima. He is also the Director of the Institute of Studies in Health, Sexuality and Human Development. He obtained his MD degree (1988) from UPCH, and his MPH (1991) and PhD (1996) degrees from UC Berkeley. Throughout the last 20+ years he has led numerous studies on HIV/AIDS and sexual health with populations of MSM, transgender women and people living with HIV. He has also conducted extensive research on health policy and systems, focusing on the Global Fund (GFATM) and the National Response to HIV. Apart from his research experience, he has served as a consultant to various UN bodies for diverse planning, research, and training activities. He coordinates the Network for Multidisciplinary studies in ARV-Based HIV Prevention (NEMUS). He was the founder and Past President of the International Association for the Study of Sexuality, Culture and Society, and was a member of the IAS Governing Council (2010-14). In 2014 he was appointed to serve at the Technical Review Panel of the GFATM.

     

    The webinar is scheduled to take place on Wednesday 22 March, 2017, at 7:00 am Los Angeles; 8:00 am Mexico; 9:00 Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 2:00 pm London; 3:00 pm Geneva; 4:00 pm Johannesburg; 7.30 pm India, 9:00 pm Bangkok. To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/lKPJGIuYRCkWxUv42

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Series # 28:"The PrEP Task Force in Latin America and the Caribbean: A model of technical support for evidence-based HIV PrEP Implementation"

    Dear colleague:

     

    After the completion of important studies providing evidence of the efficacy of PrEP for HIV prevention in various populations, translated into technical recommendations for use by people at increased risk in the context of combination HIV prevention, released by WHO, it is necessary to focus increasingly on tasks that will support countries in assessing the potential role of PrEP in their HIV prevention responses, based on evidence, and eventually help in the roll-out of PrEP as one option for HIV prevention to be used by those who need and want it.

    One of those initiatives is the PrEP Task Force in Latin America and the Caribbean, which emerged as a joint initiative of the PAHO HIV Program (through Dr. Giovanni Ravasi) and NEMUS (through Dr. Carlos Cáceres).

    At this time, we are pleased to announce the next NEMUS Global Webinar to be focused on

    The PrEP Task Force in Latin America and the Caribbean: A model of technical support for evidence-based HIV PrEP Implementation

     

    Giovanni Ravasi

    Giovanni Ravasi. is a Medical Doctor, specialized in Infectious Diseases from the Universitá degli Studi of Pavia, Italy, and holds a Master Degree in Public Health from the London School of Hygiene in Tropical Medicine, London, UK. Since 2008 works as Regional Adviser on HIV for the Pan American Health Organization (PAHO), Regional office of the World Health Organization (WHO), based in Brasilia, Brazil, until 2013, and since 2014 in the Regional Headquarter in Washington DC, USA. His main areas of work are HIV drug resistance surveillance, prevention and control, technical cooperation for HIV care and treatment public health policy development, implementation and monitoring and evaluation.

     

    Ioannis

    Dr. Ioannis (Yannis) Hodges-Mameletzis, WHO. He is an HIV molecular epidemiologist and biologist by training, based in Geneva, Switzerland. He is currently consulting on PrEP at WHO Headquarters and is involved in supporting countries around the technical and programmatic issues around PrEP implementation. He has been extensively involved in the development of evidence-based recommendations for HIV and viral hepatitis at WHO.

     

    carlosfcaceresp 200

    Carlos Cáceres, MD, MPH, PhD. is a Professor of Public Health, and Director of the Center for Interdisciplinary Studies in HIV, AIDS and Society at Cayetano Heredia University (UPCH) in Lima. He is also the Director of the Institute of Studies in Health, Sexuality and Human Development. He obtained his MD degree (1988) from UPCH, and his MPH (1991) and PhD (1996) degrees from UC Berkeley. Throughout the last 20+ years he has led numerous studies on HIV/AIDS and sexual health with populations of MSM, transgender women and people living with HIV. He has also conducted extensive research on health policy and systems, focusing on the Global Fund (GFATM) and the National Response to HIV. Apart from his research experience, he has served as a consultant to various UN bodies for diverse planning, research, and training activities. He coordinates the Network for Multidisciplinary studies in ARV-Based HIV Prevention (NEMUS). He was the founder and Past President of the International Association for the Study of Sexuality, Culture and Society, and was a member of the IAS Governing Council (2010-14). In 2014 he was appointed to serve at the Technical Review Panel of the GFATM.

     

    The webinar is scheduled to take place on Wednesday 22 March, 2017, at 7:00 am Los Angeles; 8:00 am Mexico; 9:00 Lima, Panama City; 10:00 New York; 11:00 am Brasilia; 2:00 pm London; 3:00 pm Geneva; 4:00 pm Johannesburg; 7.30 pm India, 9:00 pm Bangkok. To check the time in your specific time zone, please visit:

    http://www.worldtimeserver.com/meeting-planner.aspx

    To register for the webinar please click on the following link:

     

    https://goo.gl/forms/lKPJGIuYRCkWxUv42

     

    After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

     

    Read more

  • NEMUS Webinar Latina# 8: "Situación y Perspectivas del Acceso a…

    Estimadas y estimados colegas:

     

    Reciban un saludo por el inicio de este año 2017, cuyo primer mes ha pasado muy rápidamente​. ​Son tiempos en que las discusiones sobre la implementación de PrEP van haciéndose más frecuentes y sostenidas en la región, con planes ​​crecientes de estudios complementarios que permitan obtener mayor evidencia para decidir su inclusión en la respuesta programática, o para adaptarlo al sistema de salud de países determinados. Por ello, ​continuaremos con la presentación de experiencias de interés, o resultados de investigaciones relevantes. En ese sentido, ​el proximo jueves​ ​2 de Febrero,​​ el Dr.​ ​Hamid Vega y el ​Lic. Steven Díaz de las Clinicas Especializadas Condesa-Iztapalapa de la Ciudad de México,​ nos presentará​​n:

     

    "Situación y Perspectivas del Acceso a PrEP para la Prevención del VIH en México"

     

    Hamid Vega

    Hamid Vega es médico psiquiatra egresado del Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”. Doctorante en Salud Mental Pública por la UNAM. Coordinador del Programa de Salud Mental de la Clínicas Especializadas Condesa y Condesa-Iztapalapa. Es miembro del Comité Técnico Consultivo sobre VIH e ITS de la OPS. Junto con su equipo, se encargan de la atención clínica e investigación de los trastornos mentales en las personas con VIH y otras minorías sexuales.

     

    Steven Diego

    Steven Diego estudió Psicología y Matemáticas en la Universidad del Estado de Illinois. También tiene formación en Promoción y Educación en Salud Pública. Tiene más de 30 diplomados en temas de enfermedades infecciosas (incluyendo VIH) en E.U.A. y Latinoamérica. Su experiencia en VIH, tanto en prevención como en provisión de servicios, ha sido desarrollada en Estados Unidos, México, Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panamá, Perú, Ecuador, Brasil, Argentina y Chile. Actualmente es el Subdirector de Prevención e Información para el Centro para la prevención Integral del VIH/sida de la Ciudad de México.

     

    El webinar se desarrollará el Jueves 02 de Febrero de 2017 a las ​7​:00 am en Los Angeles, 9:00am en C. de ​México, C. de ​Guatemala, y San José; 10.00am en ​Nueva York, ​Lima​, Bogotá​, Quito​, ​​C. de Panamá​ y Washington​; ​1​2m ​en ​Buenos Aires​ y Santiago​; 1:00pm en ​Rio de Janeiro y ​Brasilia, ​3​:00pm en Lisboa y Londres; y ​4​pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

     

    Read more

    close
    wxxxxxxxxxx
    NEMUS Webinar Latina# 8: "Situación y Perspectivas del Acceso a PrEP para la Prevención del VIH en México"

    Estimadas y estimados colegas:

     

    Reciban un saludo por el inicio de este año 2017, cuyo primer mes ha pasado muy rápidamente​. ​Son tiempos en que las discusiones sobre la implementación de PrEP van haciéndose más frecuentes y sostenidas en la región, con planes ​​crecientes de estudios complementarios que permitan obtener mayor evidencia para decidir su inclusión en la respuesta programática, o para adaptarlo al sistema de salud de países determinados. Por ello, ​continuaremos con la presentación de experiencias de interés, o resultados de investigaciones relevantes. En ese sentido, ​el proximo jueves​ ​2 de Febrero,​​ el Dr.​ ​Hamid Vega y el ​Lic. Steven Díaz de las Clinicas Especializadas Condesa-Iztapalapa de la Ciudad de México,​ nos presentará​​n:

     

    "Situación y Perspectivas del Acceso a PrEP para la Prevención del VIH en México"

     

    Hamid Vega

    Hamid Vega es médico psiquiatra egresado del Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”. Doctorante en Salud Mental Pública por la UNAM. Coordinador del Programa de Salud Mental de la Clínicas Especializadas Condesa y Condesa-Iztapalapa. Es miembro del Comité Técnico Consultivo sobre VIH e ITS de la OPS. Junto con su equipo, se encargan de la atención clínica e investigación de los trastornos mentales en las personas con VIH y otras minorías sexuales.

     

    Steven Diego

    Steven Diego estudió Psicología y Matemáticas en la Universidad del Estado de Illinois. También tiene formación en Promoción y Educación en Salud Pública. Tiene más de 30 diplomados en temas de enfermedades infecciosas (incluyendo VIH) en E.U.A. y Latinoamérica. Su experiencia en VIH, tanto en prevención como en provisión de servicios, ha sido desarrollada en Estados Unidos, México, Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panamá, Perú, Ecuador, Brasil, Argentina y Chile. Actualmente es el Subdirector de Prevención e Información para el Centro para la prevención Integral del VIH/sida de la Ciudad de México.

     

    El webinar se desarrollará el Jueves 02 de Febrero de 2017 a las ​7​:00 am en Los Angeles, 9:00am en C. de ​México, C. de ​Guatemala, y San José; 10.00am en ​Nueva York, ​Lima​, Bogotá​, Quito​, ​​C. de Panamá​ y Washington​; ​1​2m ​en ​Buenos Aires​ y Santiago​; 1:00pm en ​Rio de Janeiro y ​Brasilia, ​3​:00pm en Lisboa y Londres; y ​4​pm en Madrid y París. Para otros países/ciudades, por favor visite:

     

    http://www.worldtimeserver.com/meeting-planner.aspx

     

    Para registrarse para el webinar, por favor ingrese en:

     

    https://goo.gl/forms/fewkFsAplFqzVbZv1

     

    Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

     

     

     

    Read more

Nemus TV

We plan to broadcast presentations and events relevant to NEMUS

Why register?

 

We hope to reach two kinds of users of this website:

a) General users (unregistered), with non-specific or temporary interest on this topic. They will access the general content and most of the resources.

b) Registered Members, who will have to register initially, and then to log-in for access. They will be identified by name and contact information (although this list will be internal), and will provide details of their background connection with the topic. It is assumed that they have closer links with the issue of ARV-based prevention (through their work as prevention programme managers, health care providers, advocates, and researchers). They will have access to discussions 'by invitation only' and draft documents of restricted circulation. They will become members of NEMUS.

If you wish to become a member, please

 

Register now

Contact Us

We will reply to each and every submission. If there are any new projects or publications we should know about please feel free to drop us a line with the details

Name must not be empty
Please provide a valid email
Message should not be empty
Captcha should not be empty

NEMUS Secretariat

 

Unit of Health, Sexuality and Human Development
Cayetano Heredia University
Av. Armendariz 445, Miraflores
Lima 18, Peru

511.203.3300

nemus.secretariat[at]nemus-hiv.net

Newsletter

 

We will publish a bimonthly bulletin with original notes or links to notes that are relevant to NEMUS' activities, including research initiatives and findings, policy debates, dissemination efforts, among others.